A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: study protocol for a randomized controlled trial

BACKGROUND: A growing population of patients lives with severe coronary artery disease not amenable to coronary revascularization and with refractory angina despite optimal medical therapy. Percutaneous reduction of the coronary sinus is an emerging treatment for myocardial ischemia that increases c...

Descripción completa

Detalles Bibliográficos
Autores principales: Jolicœur, E Marc, Banai, Shmuel, Henry, Timothy D, Schwartz, Marc, Doucet, Serge, White, Christopher J, Edelman, Elazer, Verheye, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599995/
https://www.ncbi.nlm.nih.gov/pubmed/23413981
http://dx.doi.org/10.1186/1745-6215-14-46

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599995/
https://www.ncbi.nlm.nih.gov/pubmed/23413981
http://dx.doi.org/10.1186/1745-6215-14-46

Ejemplares similares